Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma

ERJ Open Res. 2021 Aug 16;7(3):00190-2021. doi: 10.1183/23120541.00190-2021. eCollection 2021 Jul.

Abstract

Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC.